Purdue Pharma’s $7.4 Billion Settlement: What It Could Mean for Australia
The $7.4 billion Purdue Pharma settlement has rocked the U.S. legal and healthcare landscape — but the ripple effects may reach Australia. From legal liability and class actions to changes in how doctors prescribe opioids, this case raises urgent questions for Australian regulators, patients, and professionals alike.